U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
137071137071Cardiovascular Risk Stratification in Patients With Obstructive Sleep ApneaRecruitingNo Results AvailableObstructive Sleep Apnea|Obesityhttps://ClinicalTrials.gov/show/NCT00768625
137072137072Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaWithdrawnNo Results AvailableSchizophreniaDrug: SCA-136 50mg/day|Drug: SCA-136 150 mg/day|Drug: SCA-136 300mg/day|Drug: Risperidone 4mg/dayhttps://ClinicalTrials.gov/show/NCT00768612
137073137073A Study of Econazole Foam 1% in Athlete's FootCompletedHas ResultsTinea Pedis|Athlete's FootDrug: Econazole Nitrate Cream 1%|Drug: Econazole Nitrate Foam 1%|Drug: Vehicle Foamhttps://ClinicalTrials.gov/show/NCT00768599
137074137074Analysis of the Early Development of the Visual Function in Extreme Premature Infants Under 28th Weeks of GestationRecruitingNo Results AvailableVisionhttps://ClinicalTrials.gov/show/NCT00768586
137075137075Taste Test of a New Formulation of Sildenafil (Revatio)CompletedNo Results AvailableNone VolunteerDrug: sildenafilhttps://ClinicalTrials.gov/show/NCT00768573
137076137076Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD StudyCompletedHas ResultsHypertensionDrug: Nifedipine (Adalat CR, BAYA1040) 80mg OD|Drug: Nifedipine (Adalat CR, BAYA1040) 40mg BID|Drug: Nifedipine (Adalat CR, BAYA1040) 40mg ODhttps://ClinicalTrials.gov/show/NCT00768560
137077137077Risk Stratification in Acutely Admitted Medical PatientsCompletedNo Results AvailableHematologic Testshttps://ClinicalTrials.gov/show/NCT00768547
137078137078Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis MediaRecruitingNo Results AvailableOtitis Mediahttps://ClinicalTrials.gov/show/NCT00768534
137079137079A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)CompletedHas ResultsOveractive BladderDrug: tolterodine tartrate|Drug: Comparator: Placebo to tolterodine tartratehttps://ClinicalTrials.gov/show/NCT00768521
137080137080Combined Pharmacotherapies for AlcoholismCompletedNo Results AvailableAlcoholismDrug: Ondansetron 4 ug/kg b.i.d. + Cognitive Behavioral Therapy|Drug: Naltrexone 50 mg/day + Cognitive Behavioral Therapy|Drug: Ondansetron 4 ug/kg b.i.d.+ Naltrexone 50 mg/day + Cognitive Behavioral Therapy|Other: Placebo + Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00768508
137081137081Hyperspectral Imaging Pre and Post Endovascular InterventionRecruitingNo Results AvailableChronic Limb Ischemia|Non-Healing Ulcershttps://ClinicalTrials.gov/show/NCT00768495
137082137082A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid DependenceTerminatedNo Results AvailableOpioid DependenceDrug: Probuphine (buprenorphine implant)|Drug: Sublingual Buprenorphinehttps://ClinicalTrials.gov/show/NCT00768482
137083137083Study Evaluating Safety And Tolerability, Solid TumorCompletedNo Results AvailableAdvanced Malignant Solid TumorsDrug: HKI-272 + Paclitaxelhttps://ClinicalTrials.gov/show/NCT00768469
137084137084Local Infiltration Analgesia With Ropivacaine Versus Placebo in Vaginal Hysterectomy: a Randomized, Double-Blind StudyCompletedNo Results AvailablePain, Postoperative|Postoperative Nausea and VomitingDrug: Ropivacaine 0.5 %|Drug: Isotonic NaClhttps://ClinicalTrials.gov/show/NCT00768456
137085137085Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)CompletedNo Results AvailableGastroesophageal Reflux Diseasehttps://ClinicalTrials.gov/show/NCT00768443
137086137086Optimization of IV Ketamine for Treatment Resistant DepressionCompletedHas ResultsMajor Depressive Disorder (MDD)|Treatment Resistant Depression (TRD)Drug: Ketamine|Drug: Midazolamhttps://ClinicalTrials.gov/show/NCT00768430
137087137087Availability of Lipids in Almonds in Healthy IndividualsCompletedNo Results AvailableObesity|OverweightBehavioral: 10 chews|Behavioral: 25 Chews|Behavioral: 40 Chewshttps://ClinicalTrials.gov/show/NCT00768417
137088137088A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal ImpairmentCompletedNo Results AvailableRenal ImpairmentDrug: Topirmate and Phenterminehttps://ClinicalTrials.gov/show/NCT00768404
137089137089Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is AvailableCompletedNo Results AvailableSolid TumorsBiological: IMC-3G3https://ClinicalTrials.gov/show/NCT00768391
137090137090Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.CompletedNo Results AvailableVestibular Diseases|Gait DisordersDevice: Training with the BrainPort balance devicehttps://ClinicalTrials.gov/show/NCT00768378
137091137091Cardiovascular Risk in Patients With Non-Functional Adrenal IncidentalomaCompletedNo Results AvailableAdrenal Cortex Neoplasmshttps://ClinicalTrials.gov/show/NCT00768365
137092137092Educational Intervention for Optimizing Adolescent Mental Health Screening and Treatment in Pediatric ResidencyRecruitingNo Results AvailableMental HealthOther: Educational interventionhttps://ClinicalTrials.gov/show/NCT00768352
137093137093A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell LymphomasTerminatedNo Results AvailableLeukemia, Lymphocytic, Chronic, B-Cell|Lymphoma, B-CellDrug: AEG35156 antisense IV infusionhttps://ClinicalTrials.gov/show/NCT00768339
137094137094Efficacy of Lu 31-130 in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Zicronapine|Drug: Zicronapine|Drug: Zicronapine|Drug: Zicronapine|Drug: Zicronapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00768326
137095137095Phase IV Comparing Rods of Yield Strengths to Correct Adolescent Idiopathic Scoliosis.TerminatedNo Results AvailableScoliosisDevice: titanium rod|Device: ultra strength stainless steel rodhttps://ClinicalTrials.gov/show/NCT00768313
137096137096(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPFTerminatedHas ResultsIdiopathic Pulmonary FibrosisDrug: Ambrisentan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00768300
137097137097Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia BActive, not recruitingNo Results AvailableHemophilia BBiological: IB1001 (On-Demand)|Biological: IB1001 (Prophylaxis)https://ClinicalTrials.gov/show/NCT00768287
137098137098Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL CholesterolCompletedNo Results AvailableDyslipidemia|Atherosclerosis|Acute Coronary Syndrome|Cardiovascular DiseaseDrug: RVX000222 (common name RVX-208)https://ClinicalTrials.gov/show/NCT00768274
137099137099Corticolimbic Degeneration and Treatment of DementiaCompletedNo Results AvailableDementiaDrug: Memantine (Namenda®)|Drug: Memantine (Namenda®)|Drug: Donepezil (Aricept®)https://ClinicalTrials.gov/show/NCT00768261
137100137100Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump PainTerminatedNo Results AvailableAmputation|Phantom Limb|Stump PainDrug: perineural ropivacaine|Drug: normal saline (placebo)https://ClinicalTrials.gov/show/NCT00768248

* Görseller ve İçerik tekif hakkına sahip olabilir